Big Pharma giant Pfizer’s annual earnings in 2022 reached $100bn, a considerable proportion of which came from its COVID-19 vaccine and antiviral treatment, Paxlovid.
The company’s $100.3bn earnings marked an all-time high for Pfizer, demonstrating a 23% increase on its earnings from 2021. Its profits for the year were $31bn, a 43% increase on the previous year.
Excluding its COVID-19 vaccine and treatment, Pfizer’s revenues grew by 2% over the entire year, and 5% in the fourth quarter.
